TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
FTH

Faeth Therapeutics, Inc.

Healthcare · Biotechnology

28.10$ +1.1% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Faeth Therapeutics, Inc. (FTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 189 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FTH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
82 74 67 60 53 45 38 32 28 23 205 189
74 67 60 54 48 42 36 30 26 22 204 189
11 13 11 12 19 10.0 9.9 13 11 8.7 152 27
72 66 58 52 47 41 34 29 25 21 203 186
11 9.5 8.2 7.6 7.5 7.0 6.3 4.5 4.6 4.3 14 16
6.2 5.6 5.0 4.9 5.4 5.4 5.2 3.9 4.4 4.3 14 9.6
2.4 2.4 2.5 2.5 2.4 2.3 2.2 2.0 1.9 1.5 1.0 0.6
2.7 1.7 2.0 1.6 1.7 0.2 0.4 0.4 0.3 0.7 3.4 2.1
71 65 58 52 46 38 32 27 23 19 191 173
-224 -232 -240 -247 -254 -262 -269 -274 -278 -283 -453 -469
1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 5.6

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?